Found: 14
Select item for more details and to access through your institution.
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2823, doi. 10.3390/pharmaceutics14122823
- By:
- Publication type:
- Article
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 11, p. 1185, doi. 10.3390/ph14111185
- By:
- Publication type:
- Article
The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 3, p. 175, doi. 10.3390/ph14030175
- By:
- Publication type:
- Article
Anti-Migratory Effect of Vinflunine in Endothelial and Glioblastoma Cells Is Associated with Changes in EB1 C-Terminal Detyrosinated/Tyrosinated Status.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0065694
- By:
- Publication type:
- Article
Specific Features of Stromal Cells Isolated from the Two Layers of Subcutaneous Adipose Tissue: Roles of Their Secretion on Angiogenesis and Neurogenesis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4214, doi. 10.3390/jcm12134214
- By:
- Publication type:
- Article
Evidences of a Direct Relationship between Cellular Fuel Supply and Ciliogenesis Regulated by Hypoxic VDAC1-ΔC.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3484, doi. 10.3390/cancers12113484
- By:
- Publication type:
- Article
Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein–VDAC complexation as a potential therapeutic target for Parkinson’s disease treatment.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 7, p. 1, doi. 10.1007/s00018-022-04389-w
- By:
- Publication type:
- Article
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC.
- Published in:
- Cellular & Molecular Life Sciences, 2020, v. 77, n. 18, p. 3611, doi. 10.1007/s00018-019-03386-w
- By:
- Publication type:
- Article
Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells.
- Published in:
- FASEB Journal, 2021, v. 35, n. 1, p. 1, doi. 10.1096/fj.202001693R
- By:
- Publication type:
- Article
Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content.
- Published in:
- FASEB Journal, 2019, v. 33, n. 7, p. 8186, doi. 10.1096/fj.201802723R
- By:
- Publication type:
- Article
The macrophage: a key player in the pathophysiology of peripheral neuropathies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Tubulin-VDAC Interaction: Molecular Basis for Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy.
- Published in:
- Frontiers in Physiology, 2019, p. N.PAG, doi. 10.3389/fphys.2019.00671
- By:
- Publication type:
- Article
Probing Membrane Association of α-Synuclein Domains with VDAC Nanopore Reveals Unexpected Binding Pattern.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-40979-8
- By:
- Publication type:
- Article